Gene Inhibition May Help Normalize Type 2 Diabetes, Yale University School Of Medicine Study

Bookmark and Share

Yale University -- New Haven, Conn. — In research that could lead to new approaches for the treatment of type 2 diabetes, a Yale School of Medicine team has found that suppressing a liver enzyme that induces glucose production helped diminish the symptoms of the disease in a rat model — reducing blood glucose concentrations, decreasing rates of glucose production in the liver, and improving insulin sensitivity. Decreasing expression of the gene, Sirtuin 1, also lowered total cholesterol levels.

Back to news